Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

by Ang, A.S.Y, Ang, L.M, Lee, J.Y, Mohd Ali, N., Omar, A.
Published 2021

Use of Low-Molecular-Weight Heparin and Peak anti-Xa Monitoring In Severe SARS-CoV-2 Disease: A Brief Report

by Drexler, N., Fatteh, N., Lozada, J., Toor, R., Zamora, F.J
Published 2021

Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: A 16-year retrospective cohort st...

by Dissaneevate, S., Janjindamai, W., Raknoo, T., Ratanajamit, C., Sitaruno, S.
Published 2021

Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study

by Bavanandan, S., Islahudin, F., Lee, F.Y, Makmor-Bakry, M., Wong, H.-S
Published 2021

Knockdown of lncRNA MALAT1 ameliorates acute kidney injury by mediating the miR-204/APOL1 pathway

by Jiang, H.-T, Lu, H.-Y, Wang, G.-Y, Zhao, J.-W
Published 2021

Lung Ultrasound Can Predict the Clinical Course and Severity of COVID-19 Disease

by Borges, I.N, Cabral, M.A.D.S, Chamon, S., de Andrade, M.V.M, de Barros, G.M, Duani, H., Marinho, C.C, Nobre, V., Nucleo de Investigacao em Medicina Intensiva (NIIMI), Ravetti, C.G, Rocha, G.C, Vassallo, P.F
Published 2021

Analysis of the diagnostic capabilities of urinary neutrophil gelatinase-associated lipocalin and serum procalcitonin for acute kidney injury at the early stage of critical care in...

by Imoto, Y., Ishikura, H., Izumida, K., Kawano, Y., Matsunaga, A., Ohkubo, K., Shimada, H., Wakasaki, A.
Published 2021

A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients

by He, M., Kang, Y., Wang, R.R
Published 2021

Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: An underrecognized adverse effect

by Ammuri, H., Elias, A., Frisch, A., Kurnik, D., Sakran, R., Sliman, H.
Published 2021

Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic

by Dauner, D.G, Dauner, K.N
Published 2021

Prediction of acute kidney injury after cardiac surgery: model development using a Chinese electronic health record dataset

by Chen, W., Chen, X., Chen, X., Tang, Y., Wang, Z., Wu, Y., You, D., Yu, M., Zhang, H., Zhao, Y.
Published 2022

Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis

by Cheng, L., Fu, P., Guo, F., Liang, Y., Ma, L., Ren, Q., Tan, Z., Wang, B., Xu, J., Yang, L.
Published 2022

Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis

by Kaze, A.D, Kim, S.C, Paik, J.M, Patorno, E., Zhuo, M.
Published 2022

The development of end stage renal disease in two patients with PMM2-CDG

by Berry, G.T, Brucker, W.J, Hecht, L.E, Rodig, N.M, Tiwary, H.
Published 2022

Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib

by Chute, D.F, Colvin, R.B, Efe, O., Fadden, R.M, Jhaveri, K.D, Kaufman, H.L, Lee, M.D, Reynolds, K.L, Rosales, I.A, Rusibamayila, N., Seethapathy, H., Sise, M.E, Strohbehn, I.A, Sullivan, R.J
Published 2022

Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants

by Babbitt, C.J, Bembea, M.M, Bradford, T.T, Campbell, A.P, Coates, B.M, Cvijanovich, N.Z, Dapul, H., Fitzgerald, J.C, Halasa, N.B, Hall, M.W, Hobbs, C.V, Irby, K., Jackson, A.M, Kong, M., Loftis, L.L, Maamari, M., Mack, E.H, Maddux, A.B, McLaughlin, G.E, Newhams, M.M, Nofziger, R.A, Patel, M.M, Randolph, A.G, Rowan, C.M, Schuster, J.E, Singh, A.R, Staat, M.A, Walker, T.C, Woodworth, K., Young, C.C
Published 2022

Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

by Bessette, L.G, Brodovicz, K.G, Déruaz-Luyet, A., Glynn, R.J, Najafzadeh, M., Paik, J.M, Patorno, E., Pawar, A., Schneeweiss, S., Wexler, D.J
Published 2022

Risk assessment for acute kidney injury and death among new COVID-19 positive adult patients without chronic kidney disease: Retrospective cohort study among three US hospitals

by Li, D., Li, Q., Lin, X., Ren, H., Sarin, P., Varelmann, D.J, Wu, D., Xu, P.
Published 2022

Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

by Amato, M.G, Bain, P.A, Bates, D.W, Co, Z., Dulgarian, S., Edrees, H., Foer, D., Kuznetsova, M., Purcell Jackson, G., Rhee, K., Seger, D.L, Simona, A., Song, W., Syrowatka, A.
Published 2022

Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States

by Badowski, M.E, Beardsley, J.R, Borkowski, J.L, Dairem, A., Fong, K., Hale, C.M, Michienzi, S.M, Moore, W.J, Pallotta, A.M, Polisetty, R.S, Postelnick, M.J, Rhodes, N.J, Schulz, L.T, Shah, A., Spivak, E.S, Srinivas, P.
Published 2021